Cita APA (7a ed.)

Blunder, S., Hermann‐Kleiter, N., Mahmuti, R., Hermann, M., Ortner, D., Reider, D., . . . Gruber, R. (2025). Blocking of IL‐4/IL‐13 Signalling With Dupilumab Results in Restoration of Serum and Cutaneous Abnormalities in Netherton Syndrome. Wiley. https://doi.org/10.1111/exd.70113

Cita Chicago Style (17a ed.)

Blunder, Stefan, et al. Blocking of IL‐4/IL‐13 Signalling With Dupilumab Results in Restoration of Serum and Cutaneous Abnormalities in Netherton Syndrome. Wiley, 2025. https://doi.org/10.1111/exd.70113.

Cita MLA (9a ed.)

Blunder, Stefan, et al. Blocking of IL‐4/IL‐13 Signalling With Dupilumab Results in Restoration of Serum and Cutaneous Abnormalities in Netherton Syndrome. Wiley, 2025. https://doi.org/10.1111/exd.70113.